High-quality plasmid DNA platforms
powering RNA，gene and cell therapies.

Integrated RNA platforms spanning mRNA,
circular RNA, and self-amplifying RNA.

Advanced lipid-based delivery systems
enabling precise in vivo targeting.

Next-generation non-lipid delivery systems
for emerging therapeutic needs

Scalable microbial manufacturing for
proteins, nanobodies, and peptides.

End-to-end GMP manufacturing and CMC
support from IND to scale-up.